Neumeier Poma Investment Counsel LLC Takes Position in Celestica, Inc. $CLS

Neumeier Poma Investment Counsel LLC purchased a new position in shares of Celestica, Inc. (NYSE:CLS) (TSE:CLS) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 2,486 shares of the technology company’s stock, valued at approximately $906,893.

Several other hedge funds and other institutional investors have also modified their holdings of CLS. Clal Insurance Enterprises Holdings Ltd acquired a new stake in Celestica during the 2nd quarter valued at approximately $1,094,000. Connor Clark & Lunn Investment Management Ltd. bought a new stake in Celestica during the 2nd quarter valued at about $674,199,000. Matters Capital LLC purchased a new position in Celestica during the second quarter valued at $796,000. Bank of Nova Scotia purchased a new position in shares of Celestica in the second quarter valued at $122,850,000. Finally, Kendall Capital Management purchased a new position in Celestica during the 2nd quarter worth $6,863,000. Institutional investors own 67.38% of the company’s stock.

Celestica Trading Down 5.1%

Shares of CLS stock traded down $16.12 during trading hours on Friday, reaching $301.26. 1,027,402 shares of the stock were exchanged, compared to its average volume of 2,438,606. The firm has a market capitalization of $34.64 billion, a price-to-earnings ratio of 31.32 and a beta of 2.06. The company has a current ratio of 1.23, a quick ratio of 0.68 and a debt-to-equity ratio of 0.32. Celestica, Inc. has a 12-month low of $183.66 and a 12-month high of $474.02. The company’s 50-day moving average price is $334.90 and its 200-day moving average price is $335.87.

Celestica (NYSE:CLS) (TSE:CLS) last issued its quarterly earnings results on Monday, July 27th. The technology company reported $2.54 earnings per share for the quarter, beating analysts’ consensus estimates of $2.29 by $0.25. The firm had revenue of $4.68 billion for the quarter, compared to analyst estimates of $4.30 billion. Celestica had a net margin of 7.16% and a return on equity of 39.96%. Celestica’s quarterly revenue was up 62.4% compared to the same quarter last year. During the same period last year, the company posted $1.39 EPS. Celestica has set its FY 2026 guidance at 11.300-11.300 EPS and its Q3 2026 guidance at 2.880-3.080 EPS. As a group, equities analysts anticipate that Celestica, Inc. will post 10.42 earnings per share for the current year.

Insider Buying and Selling

In other Celestica news, CFO Mandeep Chawla sold 16,117 shares of the business’s stock in a transaction dated Tuesday, August 4th. The stock was sold at an average price of $369.32, for a total transaction of $5,952,330.44. Following the sale, the chief financial officer owned 65,444 shares in the company, valued at approximately $24,169,778.08. The trade was a 19.76% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Robert Mionis sold 23,496 shares of the business’s stock in a transaction that occurred on Thursday, August 13th. The shares were sold at an average price of $362.39, for a total value of $8,514,715.44. Following the sale, the chief executive officer owned 23,396 shares in the company, valued at approximately $8,478,476.44. This represents a 50.11% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders have sold 356,553 shares of company stock worth $135,238,444. Corporate insiders own 1.10% of the company’s stock.

Analysts Set New Price Targets

Several brokerages recently issued reports on CLS. Stifel Nicolaus set a $500.00 target price on shares of Celestica in a research report on Tuesday, July 28th. Weiss Ratings cut shares of Celestica from a “buy (b)” rating to a “buy (b-)” rating in a research note on Thursday, August 13th. Scotiabank assumed coverage on Celestica in a report on Tuesday, August 11th. They issued a “sector outperform” rating and a $500.00 target price for the company. Barclays dropped their price objective on Celestica from $430.00 to $406.00 and set an “overweight” rating for the company in a report on Friday, August 7th. Finally, BWS Financial reaffirmed a “buy” rating on shares of Celestica in a research report on Tuesday, July 28th. One analyst has rated the stock with a Strong Buy rating, twenty-one have given a Buy rating and one has assigned a Hold rating to the company’s stock. Based on data from MarketBeat, Celestica has a consensus rating of “Buy” and an average target price of $439.81.

Celestica Company Profile

Celestica Inc is a multinational electronics manufacturing services (EMS) company that provides design, engineering, manufacturing and supply chain solutions to original equipment manufacturers across a range of industries. Headquartered in Toronto, Ontario, Canada, Celestica works with customers to develop and produce complex electronic and electro-mechanical products, integrating activities from product design and prototyping through high-volume assembly, testing and final system integration.

The company’s service offering typically includes product engineering and design support, printed circuit board assembly, box-build and systems assembly, automated test and inspection, aftermarket repair and refurbishment, and end-to-end supply chain and logistics management.